Freestone Grove Partners’s Cardinal Health CAH Stock Holding History

Freestone Grove Partners’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-329,210	Closed	-$69.6M	–	1051
2026 Q1	$69.6M	Buy	329,210 +77,019	+31%	+$16.6M	0.49%	47
2025 Q4	$51.8M	Sell	252,191 -212,379	-46%	-$40M	0.37%	78
2025 Q3	$72.9M	Buy	464,570 +153,690	+49%	+$23.7M	0.54%	39
2025 Q2	$52.2M	Sell	310,880 -188,090	-38%	-$27.9M	0.39%	87
2025 Q1	$68.7M	Buy	498,970 +188,589	+61%	+$24M	0.71%	30
2024 Q4	$36.7M	Buy	+310,381	New	+$36.2M	0.45%	73

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Freestone Grove Partners's CAH Position: Q2 2026 in Review

Freestone Grove Partners sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 329,210 shares — an estimated $69.6M sold.

Freestone Grove Partners first reported a position in CAH in Q4 2024 and held it in 6 quarters. The position peaked at $72.9M in Q3 2025. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Freestone Grove Partners reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
Freestone Grove Partners sold 329,210 Cardinal Health shares in Q2 2026, an estimated $69.6M.
Freestone Grove Partners first reported a position in Cardinal Health in Q4 2024 and held it in 6 quarters.
Freestone Grove Partners's Cardinal Health position peaked at $72.9M in Q3 2025.
1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.